NEW YORK (GenomeWeb) – Molecular diagnostics developer Curetis announced today it has acquired the real-time qPCR-based Gyronimo platform from joint owners Carpegen and Systec.
NEW YORK (GenomeWeb) – Molecular diagnostics developer Curetis announced today it has acquired the real-time qPCR-based Gyronimo platform from joint owners Carpegen and Systec.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.